China Health Technology Clarifies AGM Poll Results and Board Committee Heading

China Bozza Development Holdings Limited ( (HK:1069) ) has shared an update.

China Health Technology Group Holding Company Limited has issued a supplemental announcement correcting clerical errors in the disclosed poll results for two ordinary resolutions at its 31 December 2025 annual general meeting, specifically those relating to authorising the board to fix directors’ remuneration and to re-appoint the company’s auditor, Jon Gepsom CPA Limited, and authorise the board to fix its remuneration; the corrected figures confirm both resolutions were passed with 100% of votes cast in favour. The company also rectified a mislabelled heading regarding changes in board committee composition, clarifying that it pertains to the composition of all board committees rather than only the nomination committee, while emphasising that all other information from the original announcement remains unchanged, thereby seeking to reassure investors about the accuracy of its governance disclosures.

The most recent analyst rating on (HK:1069) stock is a Hold with a HK$0.46 price target. To see the full list of analyst forecasts on China Bozza Development Holdings Limited stock, see the HK:1069 Stock Forecast page.

More about China Bozza Development Holdings Limited

China Health Technology Group Holding Company Limited is a Hong Kong-listed company incorporated in the Cayman Islands, with a board comprising one executive director and two independent non-executive directors as of early January 2026. The company is traded on the Main Board of the Stock Exchange of Hong Kong, though this announcement focuses on governance and compliance matters rather than its operating business.

Average Trading Volume: 576,621

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$42.2M

For detailed information about 1069 stock, go to TipRanks’ Stock Analysis page.